More recently, these data have been strongly supported by Choy et al.15 who demonstrated that constitutive Notch3 signaling can drive an oncogenic program in a subset of TNBCs, thus suggesting that Notch3 activity (and not others Notch paralogues) may be clinically relevant in this BC subtype. Here, NOTCH3 is linked to breast cancer.